Antitumor Effect of 131I-Labeled Anti-VEGFR2 Targeted Mesoporous Silica Nanoparticles in Anaplastic Thyroid Cancer

Antitumor Effect of 131I-Labeled Anti-VEGFR2 Targeted Mesoporous Silica Nanoparticles in Anaplastic Thyroid Cancer

Abstract Anaplastic thyroid cancer (ATC) comprises approximately 2% of all thyroid cancers, and its median survival rate remains poor because of its resistance to conventional therapy. Vascular endothelial growth factor receptor (VEGFR)-targeted therapeutics-loaded mesoporous silica nanoparticles re...

Full description

Bibliographic Details
Main Authors: Ruiguo Zhang, Yueqian Zhang, Jian Tan, Hanjie Wang, Guizhi Zhang, Ning Li, Zhaowei Meng, Fuhai Zhang, Jin Chang, Renfei Wang
Format: Article
Language:English
Published: SpringerOpen 2019-03-01
Series:Nanoscale Research Letters
Subjects:
Anaplastic thyroid cancer
ATC
Vascular endothelial growth factor receptor
VEGFR
Mesoporous silica nanoparticles
MSNs
Online Access:http://link.springer.com/article/10.1186/s11671-019-2924-z

Internet

http://link.springer.com/article/10.1186/s11671-019-2924-z

Similar Items